Venus Medtech (Hangzhou) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.29	158.34	298.04	774.4	1,879	2,955
Short-Term Investments	-	-	7.67	7.24	-	-
Trading Asset Securities	-	105.43	-	-	-	-
Cash & Short-Term Investments	71.29	263.77	305.7	781.64	1,879	2,955
Cash Growth	-75.70%	-13.72%	-60.89%	-58.41%	-36.40%	9.12%
Accounts Receivable	92.63	99.24	198.57	290.61	303.39	302.1
Other Receivables	-	64.62	55.04	58.27	80.75	53.8
Receivables	204.8	274.82	362.17	455.05	384.14	355.89
Inventory	93.02	96.75	98.06	112.94	104.4	90.52
Prepaid Expenses	-	-	-	0.28	1.07	1.02
Other Current Assets	93.12	31.66	36.54	258.17	99.93	36.98
Total Current Assets	462.23	667	802.48	1,608	2,469	3,440
Property, Plant & Equipment	93.38	116.24	522.11	693.47	461.28	250.75
Long-Term Investments	242.8	252.11	414.59	510	477.08	569.53
Goodwill	985.04	1,017	1,040	1,024	1,239	519.71
Other Intangible Assets	363.79	393.83	439.72	551.02	611.17	304.74
Long-Term Deferred Tax Assets	34.16	31.59	24.47	17.66	9.94	8.17
Other Long-Term Assets	42.21	42.18	6.76	9.15	15.86	16.93
Total Assets	2,224	2,519	3,250	4,414	5,283	5,109

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	15.87	15.95	30.23	33.86	9.13	8.75
Accrued Expenses	-	32.43	52.41	35.12	44.91	41.71
Short-Term Debt	5.04	5	17.52	136.83	100.12	0.5
Current Portion of Long-Term Debt	157.9	-	-	320.14	122.49	4.4
Current Portion of Leases	32.33	36.35	38.59	37.72	23.46	17.73
Current Income Taxes Payable	9.45	9.76	0.06	2.16	5.01	0.48
Current Unearned Revenue	5.41	2.49	3.21	29.54	4.32	17.84
Other Current Liabilities	128.63	138.62	219.74	209.79	182.68	117.13
Total Current Liabilities	354.63	240.6	361.75	805.17	492.1	208.53
Long-Term Debt	-	154.21	265.46	248.93	573.38	-
Long-Term Leases	7.42	20.78	47.53	82.56	80.2	48.15
Long-Term Unearned Revenue	-	-	-	1.63	0.6	-
Long-Term Deferred Tax Liabilities	-	-	-	17.78	17.41	53.45
Other Long-Term Liabilities	335.51	341.22	363.94	338.31	487.83	167.48
Total Liabilities	697.56	756.81	1,039	1,494	1,652	477.61

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	441.01	441.01	441.01	441.01	441.01	441.01
Additional Paid-In Capital	-	5,112	5,112	5,112	5,112	5,112
Retained Earnings	-	-4,004	-3,596	-2,882	-2,178	-1,120
Treasury Stock	-	-72.55	-72.55	-72.55	-72.55	-72.55
Comprehensive Income & Other	1,085	285.75	326.48	321.72	305.18	185.25
Total Common Equity	1,526	1,763	2,211	2,921	3,608	4,546
Minority Interest	-	-	-	-1.3	23.45	86.21
Shareholders' Equity	1,526	1,763	2,211	2,919	3,631	4,632
Total Liabilities & Equity	2,224	2,519	3,250	4,414	5,283	5,109

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	202.69	216.34	369.09	826.19	899.64	70.78
Net Cash (Debt)	-131.4	47.43	-63.39	-44.55	979.79	2,884
Net Cash Growth	-	-	-	-	-66.03%	7.81%
Net Cash Per Share	-0.30	0.11	-0.14	-0.10	2.24	6.58
Filing Date Shares Outstanding	437.9	437.9	437.9	437.9	437.9	437.9
Total Common Shares Outstanding	437.9	437.9	437.9	437.9	437.9	437.9
Working Capital	107.6	426.39	440.73	802.9	1,977	3,231
Book Value Per Share	3.48	4.03	5.05	6.67	8.24	10.38
Tangible Book Value	177.22	352.3	731.74	1,345	1,758	3,721
Tangible Book Value Per Share	0.40	0.80	1.67	3.07	4.01	8.50
Machinery	-	149.87	156.38	170.96	147.48	83.65
Construction In Progress	-	0.54	427.18	394.6	162.14	54.89
Leasehold Improvements	-	56.09	81.66	96.62	91.21	44.26